To provide a proof‐of‐concept study, we established a CCl4‐induced experimental mouse model of chronic liver damage, and demonstrated that repeated intrahepatic injections, once every 10 days for up to six times, of Ad‐IL10 mixed with CMC effectively alleviated the development of hepatic fibrosis. The gene discussed is IL10; the disease is Hepatic fibrosis.